These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14636064)

  • 1. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
    Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
    Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.
    Kondo M; Shibata T; Kumagai T; Osawa T; Shibata N; Kobayashi M; Sasaki S; Iwata M; Noguchi N; Uchida K
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7367-72. PubMed ID: 12032289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses.
    Uchida K; Shibata T
    Chem Res Toxicol; 2008 Jan; 21(1):138-44. PubMed ID: 18052108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
    Ishii T; Uchida K
    Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
    Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
    Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
    Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M; Maeyama K
    Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
    Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
    Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
    Kansanen E; Kivelä AM; Levonen AL
    Free Radic Biol Med; 2009 Nov; 47(9):1310-7. PubMed ID: 19573595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH; Surh YJ
    Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
    Hironaka A; Morisugi T; Kawakami T; Miyagi I; Tanaka Y
    Biochem Biophys Res Commun; 2009 Dec; 390(2):290-4. PubMed ID: 19799872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
    Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T; Moriya T; Nakahata N
    Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
    Campo PA; Das S; Hsiang CH; Bui T; Samuel CE; Straus DS
    Cell Growth Differ; 2002 Sep; 13(9):409-20. PubMed ID: 12354750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
    Kim DH; Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
    Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.